These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29996072)

  • 1. Promise of Immune Therapies in Multiple Myeloma.
    Anderson KC
    J Oncol Pract; 2018 Jul; 14(7):411-413. PubMed ID: 29996072
    [No Abstract]   [Full Text] [Related]  

  • 2. Advances in immunotherapy in multiple myeloma.
    Boussi L; Niesvizky R
    Curr Opin Oncol; 2017 Nov; 29(6):460-466. PubMed ID: 28877078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facts and Hopes in Multiple Myeloma Immunotherapy.
    Sperling AS; Anderson KC
    Clin Cancer Res; 2021 Aug; 27(16):4468-4477. PubMed ID: 33771856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunotherapy era of myeloma: monoclonal antibodies, vaccines, and adoptive T-cell therapies.
    Hoyos V; Borrello I
    Blood; 2016 Sep; 128(13):1679-87. PubMed ID: 27506540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Strategies in Multiple Myeloma: Immunotherapy as a Novel Approach to Treat Patients with Multiple Myeloma.
    Neri P; Bahlis NJ; Lonial S
    Clin Cancer Res; 2016 Dec; 22(24):5959-5965. PubMed ID: 27797968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunodeficiency and immunotherapy in multiple myeloma.
    Pratt G; Goodyear O; Moss P
    Br J Haematol; 2007 Sep; 138(5):563-79. PubMed ID: 17686051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Therapies in Multiple Myeloma.
    Kumar SK; Anderson KC
    Clin Cancer Res; 2016 Nov; 22(22):5453-5460. PubMed ID: 28151713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular immunotherapy in multiple myeloma: lessons from preclinical models.
    Binsfeld M; Fostier K; Muller J; Baron F; Schots R; Beguin Y; Heusschen R; Caers J
    Biochim Biophys Acta; 2014 Dec; 1846(2):392-404. PubMed ID: 25109893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to Train Your T Cells: Overcoming Immune Dysfunction in Multiple Myeloma.
    Cohen AD; Raje N; Fowler JA; Mezzi K; Scott EC; Dhodapkar MV
    Clin Cancer Res; 2020 Apr; 26(7):1541-1554. PubMed ID: 31672768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Immunotherapeutic Agents for the Treatment of Multiple Myeloma.
    Rafei H; Haroun F; Tabbara IA
    Am J Clin Oncol; 2019 Mar; 42(3):317-329. PubMed ID: 30557165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the future of immunotherapy in multiple myeloma?
    Rasche L; Hudecek M; Einsele H
    Blood; 2020 Nov; 136(22):2491-2497. PubMed ID: 32735639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-Cell Engagers - Modern Immune-Based Therapies for Multiple Myeloma.
    Mailankody S; Landgren O
    N Engl J Med; 2022 Aug; 387(6):558-561. PubMed ID: 35947712
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunotherapy for the treatment of multiple myeloma.
    Jung SH; Lee HJ; Vo MC; Kim HJ; Lee JJ
    Crit Rev Oncol Hematol; 2017 Mar; 111():87-93. PubMed ID: 28259300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune therapies.
    Prabhala RH; Munshi NC
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1217-30, x-xi. PubMed ID: 17996595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the Immune Response in Disease Progression and Therapy in Multiple Myeloma.
    Lee SJ; Borrello I
    Cancer Treat Res; 2016; 169():207-225. PubMed ID: 27696265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune therapy in multiple myeloma.
    Luptakova K; Avigan D
    Clin Adv Hematol Oncol; 2015 Nov; 13(11):767-75. PubMed ID: 27058703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy.
    Chung C
    Pharmacotherapy; 2017 Jan; 37(1):129-143. PubMed ID: 27870103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy for multiple myeloma.
    Kröger N; Mohty M; Nagler A; Yi Q
    Clin Dev Immunol; 2012; 2012():797165. PubMed ID: 23346187
    [No Abstract]   [Full Text] [Related]  

  • 19. Is immunotherapy here to stay in multiple myeloma?
    Rodríguez-Otero P; Paiva B; Engelhardt M; Prósper F; San Miguel JF
    Haematologica; 2017 Mar; 102(3):423-432. PubMed ID: 28082344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy strategies for multiple myeloma: the present and the future.
    Locke FL; Nishihori T; Alsina M; Kharfan-Dabaja MA
    Immunotherapy; 2013 Sep; 5(9):1005-20. PubMed ID: 23998734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.